ResearcherKyushu UniversityNo recent work listed
Tadashi Kayashima
Matched on OpenAlex author ID A5020027305. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2011: 3 papers · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper
Papers 6
- Hepaticocholecystojejunostomy as effective palliative biliary bypass for unresectable pancreatic cancer. First author PMID 24895820↗
- Combination therapy of portal vein resection and adjuvant gemcitabine improved prognosis of advanced pancreatic cancer. First author DOI 10.1016/j.jss.2011.11.714↗
- Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1245/s10434-011-1970-2↗
- MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Co-author DOI 10.1016/j.surg.2011.06.017↗
- Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia. Co-author DOI 10.1111/j.1349-7006.2011.01936.x↗
- MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. Co-author DOI 10.1245/s10434-011-1602-x↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masao Tanaka · 6 shared papers, 2011–2014 · strength 0.19
- Paper Hepaticocholecystojejunostomy as effective palliative biliary bypass for unresectable pancreatic cancer. PMID 24895820↗
- Paper Combination therapy of portal vein resection and adjuvant gemcitabine improved prognosis of advanced pancreatic cancer. DOI 10.1016/j.jss.2011.11.714↗
- Paper Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-011-1970-2↗
- Takao Ohtsuka · 4 shared papers, 2011–2014 · strength 0.14
- Paper Hepaticocholecystojejunostomy as effective palliative biliary bypass for unresectable pancreatic cancer. PMID 24895820↗
- Paper Combination therapy of portal vein resection and adjuvant gemcitabine improved prognosis of advanced pancreatic cancer. DOI 10.1016/j.jss.2011.11.714↗
- Paper Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-011-1970-2↗
- Masafumi Nakamura · 3 shared papers, 2012–2014 · strength 0.11
- Paper Hepaticocholecystojejunostomy as effective palliative biliary bypass for unresectable pancreatic cancer. PMID 24895820↗
- Paper Combination therapy of portal vein resection and adjuvant gemcitabine improved prognosis of advanced pancreatic cancer. DOI 10.1016/j.jss.2011.11.714↗
- Paper Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-011-1970-2↗
- Hayato Fujita · 4 shared papers, 2011–2012 · strength 0.10
- Paper Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-011-1970-2↗
- Paper Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia. DOI 10.1111/j.1349-7006.2011.01936.x↗
- Paper MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. DOI 10.1245/s10434-011-1602-x↗
- Kenoki Ohuchida · 4 shared papers, 2011–2012 · strength 0.10
- Paper Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-011-1970-2↗
- Paper Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia. DOI 10.1111/j.1349-7006.2011.01936.x↗
- Paper MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. DOI 10.1245/s10434-011-1602-x↗
- Junji Ueda · 3 shared papers, 2011–2014 · strength 0.10
- Paper Hepaticocholecystojejunostomy as effective palliative biliary bypass for unresectable pancreatic cancer. PMID 24895820↗
- Paper Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia. DOI 10.1111/j.1349-7006.2011.01936.x↗
- Paper MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. DOI 10.1245/s10434-011-1602-x↗
- Yasuhisa Mori · 2 shared papers, 2013–2014 · strength 0.08
- Kohei Nakata · 2 shared papers, 2011 · strength 0.05
- Lin Cui · 2 shared papers, 2011 · strength 0.05
- Hiroshi Kono · 1 shared paper, 2013 · strength 0.04
- Kosuke Tsutsumi · 1 shared paper, 2012 · strength 0.03
- Makoto Hashizume · 1 shared paper, 2011 · strength 0.03
- Yoshinao Oda · 1 shared paper, 2011 · strength 0.02
- Naoki Ikenaga · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.